Nifty
Sensex
:
:
15699.25
52727.98
142.60 (0.92%)
462.26 (0.88%)

Pharmaceuticals & Drugs

Rating :
52/99

BSE: 500259 | NSE: LYKALABS

118.45
24-Jun-2022
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  • 118.50
  • 119.50
  • 116.05
  • 117.30
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  39732
  •  46.85
  •  267.00
  •  56.15

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 338.83
  • 8.66
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 494.09
  • N/A
  • 26.70

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 47.79%
  • 7.33%
  • 37.26%
  • FII
  • DII
  • Others
  • 1.12%
  • 1.19%
  • 5.31%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -6.56
  • -4.76
  • 6.81

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 2.73
  • -2.87
  • 73.77

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 5.29
  • 15.83
  • 27.67

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -0.38
  • -2.72
  • -6.15

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 100.06
  • 148.81
  • 243.31

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Var%
Dec 21
Dec 20
Var%
Sep 21
Sep 20
Var%
Jun 21
Jun 20
Var%
Net Sales
35.19
24.26
45.05%
35.57
26.81
32.67%
73.89
17.46
323.20%
49.44
17.72
179.01%
Expenses
22.58
18.02
25.31%
22.55
20.80
8.41%
28.26
13.99
102.00%
19.54
13.75
42.11%
EBITDA
12.60
6.24
101.92%
13.02
6.02
116.28%
45.63
3.46
1,218.79%
29.90
3.97
653.15%
EBIDTM
35.82%
25.73%
36.60%
22.43%
61.76%
19.83%
60.48%
22.38%
Other Income
0.53
0.55
-3.64%
0.41
0.29
41.38%
0.69
0.36
91.67%
0.47
0.36
30.56%
Interest
2.99
6.37
-53.06%
4.64
6.59
-29.59%
5.57
6.60
-15.61%
6.93
6.38
8.62%
Depreciation
9.46
2.02
368.32%
2.24
2.12
5.66%
3.52
2.11
66.82%
2.13
2.08
2.40%
PBT
-2.11
-2.65
-
6.72
-1.99
-
33.33
-5.36
-
21.31
-4.14
-
Tax
12.88
-4.22
-
0.44
-0.14
-
5.66
0.36
1,472.22%
1.83
-0.06
-
PAT
-14.99
1.57
-
6.28
-1.86
-
27.68
-5.72
-
19.48
-4.09
-
PATM
-42.60%
6.48%
17.65%
-6.92%
37.45%
-32.77%
39.41%
-23.07%
EPS
-5.25
0.40
-
2.12
-0.79
-
9.91
-2.00
-
6.81
-1.63
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Jun 15
Jun 14
Mar 13
Mar 12
Net Sales
194.09
86.25
61.49
70.78
59.81
110.08
130.41
166.27
118.86
127.12
169.93
Net Sales Growth
125.03%
40.27%
-13.13%
18.34%
-45.67%
-15.59%
-21.57%
39.89%
-6.50%
-25.19%
 
Cost Of Goods Sold
52.98
37.97
35.79
39.25
29.38
53.85
70.43
90.74
64.14
66.90
102.20
Gross Profit
141.11
48.28
25.70
31.54
30.43
56.23
59.98
75.53
54.72
60.22
67.74
GP Margin
72.70%
55.98%
41.80%
44.56%
50.88%
51.08%
45.99%
45.43%
46.04%
47.37%
39.86%
Total Expenditure
92.93
66.57
65.16
72.68
63.36
87.31
110.25
137.62
110.32
105.56
154.89
Power & Fuel Cost
-
2.94
2.56
2.28
1.86
1.90
1.39
2.06
3.11
1.91
2.40
% Of Sales
-
3.41%
4.16%
3.22%
3.11%
1.73%
1.07%
1.24%
2.62%
1.50%
1.41%
Employee Cost
-
14.57
13.86
14.69
16.98
17.24
14.71
17.26
16.39
13.80
20.51
% Of Sales
-
16.89%
22.54%
20.75%
28.39%
15.66%
11.28%
10.38%
13.79%
10.86%
12.07%
Manufacturing Exp.
-
3.00
1.73
1.32
1.06
1.20
1.24
1.93
1.46
2.00
3.93
% Of Sales
-
3.48%
2.81%
1.86%
1.77%
1.09%
0.95%
1.16%
1.23%
1.57%
2.31%
General & Admin Exp.
-
4.31
5.70
5.91
5.81
5.96
6.62
7.42
5.90
5.74
7.26
% Of Sales
-
5.00%
9.27%
8.35%
9.71%
5.41%
5.08%
4.46%
4.96%
4.52%
4.27%
Selling & Distn. Exp.
-
2.65
2.27
5.17
2.95
0.37
8.61
13.20
11.03
8.85
7.05
% Of Sales
-
3.07%
3.69%
7.30%
4.93%
0.34%
6.60%
7.94%
9.28%
6.96%
4.15%
Miscellaneous Exp.
-
1.14
3.24
4.07
5.31
6.80
7.25
5.00
8.29
6.36
7.05
% Of Sales
-
1.32%
5.27%
5.75%
8.88%
6.18%
5.56%
3.01%
6.97%
5.00%
6.80%
EBITDA
101.15
19.68
-3.67
-1.90
-3.55
22.77
20.16
28.65
8.54
21.56
15.04
EBITDA Margin
52.11%
22.82%
-5.97%
-2.68%
-5.94%
20.68%
15.46%
17.23%
7.18%
16.96%
8.85%
Other Income
2.10
1.56
3.09
2.09
2.13
2.24
2.06
2.35
5.37
3.35
4.09
Interest
20.13
25.94
20.07
7.17
9.58
18.72
16.42
25.57
28.53
20.78
30.36
Depreciation
17.35
8.32
8.01
7.31
11.28
10.25
9.32
10.87
8.80
11.70
8.65
PBT
59.25
-13.02
-28.66
-14.29
-22.28
-3.97
-3.52
-5.44
-23.43
-7.56
-19.87
Tax
20.81
-4.05
0.74
-9.07
-1.04
-1.51
-0.19
1.06
1.25
0.00
0.00
Tax Rate
35.12%
28.62%
-1.20%
58.78%
5.19%
18.62%
-4.86%
-28.96%
-30.79%
0.00%
0.00%
PAT
38.45
-11.55
-60.54
-5.55
-17.21
-5.54
3.69
-4.95
-6.59
-0.71
-6.90
PAT before Minority Interest
39.01
-10.09
-62.62
-6.35
-19.00
-6.60
4.09
-4.72
-5.30
0.41
-7.53
Minority Interest
0.56
-1.46
2.08
0.80
1.79
1.06
-0.40
-0.23
-1.29
-1.12
0.63
PAT Margin
19.81%
-13.39%
-98.46%
-7.84%
-28.77%
-5.03%
2.83%
-2.98%
-5.54%
-0.56%
-4.06%
PAT Growth
480.69%
-
-
-
-
-
-
-
-
-
 
EPS
13.40
-4.02
-21.09
-1.93
-6.00
-1.93
1.29
-1.72
-2.30
-0.25
-2.40

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Jun 15
Jun 14
Mar 13
Mar 12
Shareholder's Funds
-25.80
-14.34
43.02
49.47
37.71
45.24
43.06
52.71
66.95
73.88
Share Capital
28.69
28.69
28.14
28.14
22.04
23.13
22.67
22.67
22.67
22.67
Total Reserves
-54.49
-43.03
14.12
20.57
15.67
22.11
20.07
30.05
44.29
51.21
Non-Current Liabilities
149.52
136.67
72.28
5.28
38.68
28.52
36.95
65.16
71.93
74.49
Secured Loans
150.65
125.45
78.39
4.06
34.93
25.31
28.92
50.33
53.58
55.98
Unsecured Loans
0.71
0.64
0.90
0.87
0.84
0.00
0.00
7.67
13.65
14.61
Long Term Provisions
3.66
3.86
4.08
3.63
4.39
2.92
4.30
4.20
3.85
3.04
Current Liabilities
49.24
66.32
84.81
167.12
165.45
162.83
195.24
208.09
147.21
132.46
Trade Payables
14.72
18.85
23.23
24.21
39.16
42.08
54.64
63.26
43.31
44.28
Other Current Liabilities
22.45
30.83
43.31
92.38
73.07
56.55
79.41
77.72
44.17
38.63
Short Term Borrowings
10.37
14.41
16.26
45.82
50.23
59.95
59.85
66.20
58.78
48.80
Short Term Provisions
1.70
2.23
2.02
4.72
2.99
4.26
1.35
0.91
0.96
0.75
Total Liabilities
173.66
187.88
202.85
225.23
248.87
240.50
278.76
329.26
288.90
282.53
Net Block
98.19
104.78
107.73
116.04
132.90
104.23
121.64
162.45
124.69
126.67
Gross Block
202.50
188.36
202.81
155.31
144.01
200.41
213.51
248.18
195.12
185.51
Accumulated Depreciation
104.31
83.58
95.08
39.27
11.11
96.18
91.87
85.73
70.43
58.85
Non Current Assets
144.54
152.00
167.75
176.16
186.07
158.70
177.08
211.17
162.24
167.51
Capital Work in Progress
25.75
27.76
31.07
27.88
24.23
30.17
27.03
21.78
15.38
18.83
Non Current Investment
0.01
0.01
0.01
0.23
0.26
0.39
0.32
0.30
5.53
5.52
Long Term Loans & Adv.
20.59
19.46
28.94
32.01
28.69
23.92
28.09
26.65
16.64
16.50
Other Non Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
29.12
35.88
35.11
49.07
62.79
81.81
101.69
118.09
126.66
115.01
Current Investments
0.01
0.01
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.01
Inventories
4.31
6.73
7.00
11.20
13.24
10.81
19.25
15.83
18.07
16.08
Sundry Debtors
8.67
8.04
14.63
20.50
29.17
43.29
56.70
68.02
73.40
61.03
Cash & Bank
7.15
10.30
1.71
2.43
5.12
5.56
6.51
10.71
4.80
1.83
Other Current Assets
8.98
6.54
2.13
1.74
15.25
22.14
19.23
23.54
30.38
36.07
Short Term Loans & Adv.
4.25
4.26
9.64
13.21
10.92
17.22
14.57
18.24
16.56
30.89
Net Current Assets
-20.12
-30.44
-49.70
-118.05
-102.66
-81.03
-93.55
-90.00
-20.55
-17.45
Total Assets
173.66
187.88
202.86
225.23
248.86
240.51
278.77
329.26
288.90
282.52

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Jun 15
Jun 14
Mar 13
Mar 12
Cash From Operating Activity
8.81
5.32
26.67
10.88
31.38
11.95
26.54
89.10
10.94
1.16
PBT
-14.14
-61.88
-15.42
-20.04
-8.10
3.69
-4.95
-6.59
-0.71
-6.90
Adjustment
35.40
55.76
15.17
20.79
30.53
16.15
31.64
32.87
17.41
24.14
Changes in Working Capital
-11.64
10.94
27.65
10.36
10.10
-7.57
-0.79
66.90
-5.46
-16.37
Cash after chg. in Working capital
9.62
4.82
27.39
11.10
32.53
12.27
25.90
93.17
11.24
0.87
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-0.81
0.50
-1.10
-0.44
-1.20
-0.33
-0.10
1.02
-0.42
0.57
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.12
-0.28
Extra & Other Items
0.00
0.00
0.37
0.23
0.06
0.00
0.74
-5.10
0.00
0.00
Cash From Investing Activity
-0.16
-0.11
-3.97
-3.17
-12.67
17.29
28.99
-56.87
4.54
11.87
Net Fixed Assets
-20.42
-43.81
-2.41
-3.63
12.94
-4.69
29.40
-9.46
-11.12
17.34
Net Investments
0.00
30.05
-0.01
0.00
0.12
0.00
-0.04
-42.31
0.00
0.01
Others
20.26
13.65
-1.55
0.46
-25.73
21.98
-0.37
-5.10
15.66
-5.48
Cash from Financing Activity
-11.80
3.38
-23.42
-10.41
-19.15
-30.19
-59.72
-26.32
-12.52
-16.34
Net Cash Inflow / Outflow
-3.15
8.60
-0.72
-2.69
-0.43
-0.96
-4.20
5.91
2.97
-3.31
Opening Cash & Equivalents
10.30
1.71
2.43
5.12
5.56
6.51
10.71
4.80
1.83
5.14
Closing Cash & Equivalent
7.15
10.30
1.70
2.43
5.12
5.56
6.51
10.71
4.80
1.83

Financial Ratios

Consolidated /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Jun 15
Jun 14
Mar 13
Mar 12
Book Value (Rs.)
-8.99
-5.00
15.02
16.78
15.82
16.94
14.99
18.55
25.87
26.19
ROA
-5.58%
-32.05%
-2.97%
-8.02%
-2.70%
1.58%
-1.55%
-1.72%
0.14%
-2.51%
ROE
0.00%
-448.65%
-14.20%
-46.30%
-18.27%
11.74%
-13.05%
-11.06%
0.73%
-13.12%
ROCE
8.95%
-31.39%
-5.50%
-6.52%
6.66%
12.41%
11.73%
11.93%
10.68%
12.56%
Fixed Asset Turnover
0.44
0.31
0.40
0.41
0.68
0.65
0.75
0.57
0.70
0.90
Receivable days
35.37
67.29
90.56
149.54
113.31
136.29
132.10
204.83
183.49
153.90
Inventory Days
23.36
40.77
46.92
73.58
37.61
40.97
37.15
49.11
46.62
30.61
Payable days
161.38
117.58
127.84
181.43
174.53
168.94
158.77
188.04
138.63
135.79
Cash Conversion Cycle
-102.66
-9.53
9.65
41.69
-23.60
8.32
10.48
65.90
91.48
48.72
Total Debt/Equity
-6.30
-9.85
2.28
2.39
3.60
3.12
4.05
3.97
2.62
2.31
Interest Cover
0.45
-2.08
-1.15
-1.09
0.57
1.24
0.86
0.86
1.02
0.75

News Update:


  • Lyka Labs prepays outstanding amount of Rs 48.35 crore to IARC
    31st May 2022, 15:07 PM

    The company has paid Rs 11.88 crore for RSF 1 facility and Rs 36.47 crore for TL 2 facility

    Read More
  • Lyka Labs - Quarterly Results
    20th May 2022, 19:55 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.